CONDENSED BALANCE SHEETS - USD ($)		Jun. 30, 2023	Dec. 31, 2022
Current Assets:
Cash		$ 2,520,846	$ 0
Prepaid expenses		719,261	1,200
Total current assets		3,240,107	1,200
Investments held in Trust Account		508,873,223	0
Deferred offering costs		0	511,395
Total assets		512,113,330	512,595
Current liabilities:
Accrued expenses		279,412	270,391
Liabilities, Current		279,412	503,634
Overfunding Loans		5,000,000	0
Deferred underwriting and advisory fees		17,500,000	0
Total liabilities		22,779,412	503,634
Commitments and contingencies
Shareholders’ equity (deficit)
Class A ordinary shares subject to possible redemption as of June 30, 2023		508,773,223	0
Preference shares, $0.0001 par value; 99,990,000 shares authorized(1); none issued or outstanding	[1]	0	0
Additional paid-in capital		0	23,750
Accumulated deficit		(19,440,555)	(16,039)
Total shareholders’ equity (deficit)	[2]	(19,439,305)	8,961
Total liabilities and shareholders’ equity (deficit)		512,113,330	512,595
Related Party
Current liabilities:
Promissory Note		0	233,243
Common Class A
Shareholders’ equity (deficit)
Ordinary shares	[1]	0	0
Common Class B
Shareholders’ equity (deficit)
Ordinary shares	[1],[3]	$ 1,250	$ 1,250

[1] On April 20, 2023, the Company increased the authorized share capital of the Company. All shares as of December 31, 2022 have been retroactively restated to reflect such increase (see Note 6).

[2] On April 25, 2023, the Company consummated the sale of Over-Allotment Units pursuant to the underwriters’ partial exercise of their over-allotment option. All share amounts have been retroactively restated to reflect the share surrender and share recapitalization events (see Note 4).

[3] (2) On April 25, 2023, the Company consummated the sale of Over-Allotment Units pursuant to the underwriters’ partial exercise of their over-allotment option. Share amounts as of December 31, 2022 have been retroactively restated to reflect the share surrender and share recapitalization events (see Note 4).